News

AstraZeneca and Quell Therapeutics Strike Cell Therapy Development Deal

June 14, 2023

The deal, valued at more than $2 billion dollars, will see Quell Therapeutics develop various T-regulatory cell therapies for AstraZeneca.

Croda Pharma Breaks Ground on Excipients Manufacturing Facility

June 14, 2023

The new excipients manufacturing facility is expected to be completed in 2025.

Chinook Therapeutics Acquired by Novartis AG

June 13, 2023

The merger agreement states that Novartis will acquire all the shares of Chinook through a subsidiary for a price of $40 per share in cash at closing.

mRNA Global Alliance Tests the Waters at BIO

June 12, 2023

World leaders have set ambitious goals to respond more swiftly to the next pandemic, including the US goal to design, test, and review a new vaccine just 100 days after a pandemic declaration.

New Velocity Vials Technology Platform to Expand Industry Partnerships

June 09, 2023

This will allow industry leaders to make and sell the product, in addition to providing more choice to pharma and biotech companies.

Business of Being at BIO

June 08, 2023

BIO is a powerful business development conference that can help make a lot of deals become reality.

Biosimilar CDMO Capacity Increased in Samsung Biologics – Pfizer’s New Arrangement

June 08, 2023

The collaboration between Samsung Biologics and Pfizer will focus on long-term biosimilars manufacturing.

Merck Files Lawsuit Against US Government

June 08, 2023

The complaint alleges that Medicaid price controls implemented in the Inflation Reduction Act will negatively impact biopharmaceutical innovation.

Sartorius and Waters Expand Analytics Collaboration

June 08, 2023

Sartorius and Waters will collaborate to develop integrated analytical solutions for downstream biomanufacturing.

Good Clinical Practice Draft Guidance Revealed for Clinical Studies

June 08, 2023

The document builds on key concepts outlined in ICH E8(R1) General Considerations for Clinical Studies.